Skip to main content
Premium Trial:

Request an Annual Quote

Greg Weaver, Michael French, Janet Woodcock, Alan Aderem, Charles Cantor, Michael Hanley

Two of Sirna Therapeutics’ senior executives have left the company following its recent acquisition by Merck, RNAi News has learned.
According to Bharat Chowrira, Sirna’s vice president of legal affairs and general counsel, the company’s CFO Greg Weaver and senior vice president of corporate development Michael French have left to pursue other opportunities.
Additional details were not available.
Earlier this month, Nektar Pharmaceuticals said that it had tapped Sirna’s former President and CEO Howard Robin to be its new president and CEO.

The US Food and Drug Administration has promoted deputy commissioner Janet Woodcock to chief medical officer, a newly created spot. She will retain her duties as deputy commissioner, the FDA said.
In these positions, Woodcock will be responsible for scientific and planning-related operations, including organizing, directing, staffing, coordinating, and planning.

Cyntellect has appointed three new members to its scientific advisory board.
The new members include Alan Aderem, an immunologist and cell biologist who worked at the University of Washington, and former head of the signal transduction laboratory at The Rockefeller University; Charles Cantor, chief scientific officer at Sequenom and former chair and professor of biomedical engineering at Boston University; and Michael Hanley, vice president of discovery research at Amylin Pharmaceuticals and former senior faculty at Imperial College in Cambridge, UK.

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.